Lv2
130 积分 2024-09-05 加入
Obinutuzumab for PLA2R-associated membranous nephropathy
25天前
已完结
Obinutuzumab for PLA2R-associated membranous nephropathy
25天前
已完结
Obinutuzumab in Refractory Membranous Nephropathy: A Case Series
26天前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
27天前
已完结
Mapping antigens of membranous nephropathy: almost there
2个月前
已完结
Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis
2个月前
已完结
Obinutuzumab for PLA2R-associated membranous nephropathy
3个月前
已关闭
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
4个月前
已完结
Obinutuzumab and ofatumumab are more effective than rituximab in the treatment of membranous nephropathy patients with anti-rituximab antibodies
4个月前
已完结
Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial
4个月前
已关闭
皖公网安备34019202002308
